levetít
Levetiracetam, commonly known by its brand name Keppra, is an anticonvulsant medication primarily used to treat epilepsy. It functions as an antiepileptic drug (AED) and is also prescribed off-label for other neurological conditions, such as myoclonus, partial seizures, and, in some cases, bipolar disorder. The drug was first approved for medical use in 1999 and is widely prescribed due to its effectiveness and relatively mild side effects compared to older anticonvulsants.
Levetiracetam works by modulating synaptic transmission, specifically by binding to synaptic vesicle protein 2A (SV2A), a
Common side effects of levetiracetam include dizziness, fatigue, headache, and behavioral changes such as irritability or
Levetiracetam is generally well-tolerated and does not significantly interact with many other medications, making it a
As with all medications, levetiracetam should be used under the supervision of a healthcare professional, who